Description
tecentriq price
Tecentriq is used to treat adults with non-small cell lung cancer (NSCLC), extensive-stage small cell lung cancer (SCLC), hepatocellular carcinoma, melanoma, or muscle-invasive bladder cancer (MIBC), and for patients aged 2 and older with alveolar soft part sarcoma (ASPS). It is an immunotherapy treatment given by intravenous infusion and used alone or in combination with other medicines, depending on the cancer type and stage. tecentriq price
Tumors can produce a protein called PD-L1 that suppresses the immune system’s ability to attack cancer cells. Tecentriq (atezolizumab) works by blocking PD-L1, freeing the immune system to recognize and fight the tumor. Clinical trials have reported that this blockade reduces tumor growth, with enhanced results achieved when Tecentriq is used in combination with other targeted treatments that enhance immune cell activity within the tumor. Tecentriq belongs to the drug class called PD-L1 blocking antibodies. It is also called an immune checkpoint inhibitor or monoclonal antibody. tecentriq price
Most Common Side Effects
The most common side effects of Tecentriq when used alone include:
- Feeling tired or weak
- Decreased appetite
- Nausea
- Cough
- Shortness of breath.
The most common side effects of Tecentriq when used in lung cancer with other anti-cancer medicines include:
- Feeling tired or weak
- Nausea
- Hair loss
- Constipation
- Diarrhea
- Decreased appetite.
Reviews
There are no reviews yet.